Nalaganje...
MicroRNA-30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin 1 and inhibiting autophagy
Temozolomide (TMZ) is one of the most commonly used drugs for the clinical treatment of glioblastomas. However, it has been reported that treatment with TMZ can induce autophagy, which leads to tumor resistance and increases the survival of tumor cells. MicroRNA-30a (miR-30a) has been found to have...
Shranjeno v:
| izdano v: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952084/ https://ncbi.nlm.nih.gov/pubmed/29805498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6007 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|